CERO THERAPEUTICS, INC.

Profile

Company Names

CERO THERAPEUTICS, INC.

Addresses

329 OYSTER POINT BLVD., 3RD FLOOR, SAN FRANCISCO, CA 94080

Phone Numbers

206-658-3462

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$44,649,965.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-11-14 
$43,249,966.00 
$43,249,966.00 
$0.00 
Equity 
1
2017-02-27 
$1,399,999.00 
$2,500,000.00 
$1,100,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
MARK 
COREY 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
CERO THERAPEUTICS, INC.
JORDAN 
 
COREY 
EXECUTIVE OFFICER, PROMOTER
CERO THERAPEUTICS, INC.
JORDAN 
THOMAS 
COREY 
EXECUTIVE OFFICER
CERO THERAPEUTICS, INC.
LAWRENCE 
 
COREY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CERO THERAPEUTICS, INC.   |  GRITSTONE BIO, INC.
STAN 
 
RIDDELL 
DIRECTOR
CERO THERAPEUTICS, INC.   |  LYELL IMMUNOPHARMA, INC.
STUART 
 
SLOAN 
DIRECTOR
CERO THERAPEUTICS, INC.
HEATHER 
 
TURNER 
DIRECTOR
AGRE DCP OAKLAND CITY CENTER REIT LLC   |  AGRE DCP PALM SPRINGS REIT LLC   |  CERO THERAPEUTICS, INC.   |  LYELL IMMUNOPHARMA, INC.   |  CARMOT THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-11-27
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-14 
2017-03-13
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#